SciLifeLab Programme for fUture Leaders in life SciencE

HORIZON.1.2HORIZON-TMA-MSCA-Cofund-PID: 101177199
EC Contribution
โ‚ฌ68,774
Consortium Size
31 orgs
โ–ถSummary

SciLifeLab PULSE is a MSCA-COFUND postdoctoral programme of excellence in Life Sciences coordinated by the Swedish research infrastructure SciLifeLab. PULSE will recruit 48 postdocs in academic and entrepreneurial tracks, that will receive 3 years of international interdisciplinary and intersectoral career training focused on preparing them as impactful leaders in academia and/or industry. PULSE postdocs will be immersed in the internationally recognised scientific community of Universities (10), Research Institutes (4), Infrastructures (3), Companies (12) and Associations (4), providing joint core career and specialised training and access to cutting-edge high-technology infrastructures that comprise the foundation of SciLifeLab. At the heart of PULSE is a well-conceived core training programme, augmented by secondments to ensure necessary breadth and tailored individualised training adapted and relevant to academia and industry, and to facilitate international scientific exchange. The PULSE output will be a new breed of scientists, well-prepared in the application of high-throughput technologies and data-dense analytical approaches, and who can confidently meet the emerging societal challenges confronting the European Research Area, specifically in precision medicine, pandemic laboratory preparedness, planetary biology and drug discovery and development. PULSE is aligned with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers and takes into account the MSCA supervision guidelines and Green Charter. PULSE will have an impact that extends beyond its duration, establishing dialogues with multiple stakeholders in the non-academic sector and by setting new standards in postgraduate research training in Life Sciences internationally. PULSE will be administered by the Swedish Royal Institute of Technology (KTH), and has an overall budget of 19.0 MEUR, of which 36% stems from the EC and 64% from participating institutions.

Consortium (31)

๐Ÿ‡ธ๐Ÿ‡ช KUNGLIGA TEKNISKA HOEGSKOLANSE
coordinator
๐Ÿ‡ธ๐Ÿ‡ช AFFIBODY ABSE
partner
๐Ÿ‡ธ๐Ÿ‡ช AKIRAM THERAPEUTICS ABSE
partner
๐Ÿ‡ธ๐Ÿ‡ช ASTRAZENECA ABSE
partner
๐Ÿ‡ธ๐Ÿ‡ช BEACTICA THERAPEUTICS ABSE
partner
๐Ÿ‡ธ๐Ÿ‡ช Bonsai Biotherapeutics ABSE
partner
๐Ÿ‡จ๐Ÿ‡ฆ Coronavirus Variants Rapid Response Network (CoVaRR-Net)CA
partner
๐Ÿ‡ธ๐Ÿ‡ช Cyclic Therapeutics ABSE
partner
๐Ÿ‡ธ๐Ÿ‡ช Cytiva Testa Center ABSE
partner
๐Ÿ‡ณ๐Ÿ‡ฑ EATRIS ERICNL
partner
๐Ÿ‡ฉ๐Ÿ‡ช EUROPEAN MOLECULAR BIOLOGY LABORATORYDE
partner
๐Ÿ‡ฎ๐Ÿ‡น FONDAZIONE HUMAN TECHNOPOLEIT
partner
๐Ÿ‡ธ๐Ÿ‡ช GE HEALTHCARE BIO-SCIENCES ABSE
partner
๐Ÿ‡ธ๐Ÿ‡ช LAKEMEDELSINDUSTRIFORENINGENS SERVICE AKTIEBOLAGSE
partner
๐Ÿ‡ธ๐Ÿ‡ช LIPUM ABSE
partner
๐Ÿ‡ธ๐Ÿ‡ช LUNDS UNIVERSITETSE
partner
๐Ÿ‡ธ๐Ÿ‡ช MALMO UNIVERSITETSE
partner
๐Ÿ‡ฉ๐Ÿ‡ช MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC)DE
partner
๐Ÿ‡ซ๐Ÿ‡ฎ ORION OYJFI
partner
๐Ÿ‡ธ๐Ÿ‡ช PeptiSystems ABSE
partner
๐Ÿ‡ธ๐Ÿ‡ช ProsilicoSE
partner
๐Ÿ‡ธ๐Ÿ‡ช Quretech Bio ABSE
partner
๐Ÿ‡ธ๐Ÿ‡ช RG DISCOVERY ABSE
partner
๐Ÿ‡ธ๐Ÿ‡ช Ribocure Pharmaceuticals ABSE
partner
๐Ÿ‡ธ๐Ÿ‡ช RISE Research Institutes of SwedenSE
partner
๐Ÿ‡ธ๐Ÿ‡ช Strike Pharma ABSE
partner
๐Ÿ‡ธ๐Ÿ‡ช SwedenBIO Service ABSE
partner
๐Ÿ‡ธ๐Ÿ‡ช TOLERANZIA ABSE
partner
๐Ÿ‡ซ๐Ÿ‡ฎ TURUN YLIOPISTOFI
partner
๐Ÿ‡ธ๐Ÿ‡ช UPPSALA UNIVERSITETSE
partner
๐Ÿ‡ง๐Ÿ‡ช VIB VZWBE
partner